Ірина Драпак
Ірина Драпак
доцент, кандидат фармацевтичних наук, Львівський національний медичний університет імені Данила
Подтвержден адрес электронной почты в домене meduniv.lviv.ua
Название
Процитировано
Процитировано
Год
QSAR studies of some thiazolo [4, 5-b] pyridines as novel antioxidant agents: enhancement of activity by some molecular structure parameters
O Klenina, I Drapak, T Chaban, V Ogurtsov, I Chaban, I Golos
Publishing House of Lviv Polytechnic National University, 2013
232013
Synthesis of Some Novel Thiazolo (4, 5-b) Pyridinesand their Tuberculostatic Activity Evaluation
T Chaban, O Klenina, I Drapak, V Ogurtsov, I Chaban, V Novikov
Chemistry & Chemical Technology, 287-292, 2014
212014
Synthesis of 2-(4-aryl (adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives and prediction of their biological activity
HO Yeromina, IV Drapak, LO Perekhoda, VD Yaremenko, ...
Der Pharma Chemica, 2016
152016
Cardiovascular calcium channel blockers: historical overview, development and new approaches in design
I Drapak, L Perekhoda, T Tsapko, N Berezniakova, Y Tsapko
Journal of Heterocyclic Chemistry 54 (4), 2117-2128, 2017
102017
Synthesis and in silico research of derivatives of 3-allyl-4-(R-phenyl)-N-(R1-phenyl) thiazole-2-imine
LO Perekhoda, MM Suleiman, IA Sych, VD Yaremenko
92017
Synthesis, antimicrobial and antitumor activities of 2-[5-(2-R-benzyl) thiazol-2-ylimino] thiazolidin-4-ones
I Drapak, V Foliush, T Chaban, V Matiychuk
Biointerface Res Appl Chem 10 (3), 5507-11, 2020
82020
The antioxidant properties of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one derivatives under conditions of …
LO Perekhoda, NP Kobzar, HO Yeromina, IV Drapak
82017
HPLC method development for the analysis of bisoprolol in combined dosage form containing Bisoprolol and Enalapril and in vitro dissolution studied
L Logoyda, S Kovalenko, AM AbdelMegied, I Zhulkevych, I Drapak, ...
International Journal of Applied Pharmaceutics 11 (3), 186-194, 2019
62019
Cardioprotective activity of some 2-arylimino-1, 3-thiazole derivatives
I Drapak, L Perekhoda, N Demchenko, M Suleiman, M Rakhimova, ...
Scientia Pharmaceutica 87 (1), 7, 2019
52019
The synthesis and physicochemical properties of new derivatives of 5-r-phenylamino-2-mercapto-1, 3, 4-thiadiazole
IV Sych, LO Perekhoda, ZG Ieromina, LO Grinevich, NP Kobzar, ...
News of Pharmacy, 24-28, 2016
52016
The use of the docking studies with the purpose of searching potential cardioprotectors
IV Drapak, LO Perekhoda, O Vynogradova, M Protopopov, MM Suleiman, ...
42018
Search for Biologically Active Substances with Antimicrobial and Antifungal Action in the series of 2.5-disubstituted 1, 3, 4-tiadiazoles
IV Sych, IV Drapak, MM Suleiman, MV Rakhimova, NP Kobzar, IA Sych, ...
Research Journal of Pharmacy and Technology 12 (6), 2871-2876, 2019
32019
The use of the docking studies with the purpose of searching Potential Antihypertensive Drugs
IV Drapak, MM Suleiman, MV Protopopov, HO Yeromina, IA Sych, ...
32019
QSAR-analysis of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4-yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one's derivatives as potential antioxidants
IV Drapak, BS Zimenkovsky, LO Perekhoda, HO Yeromina, K Lipakova, ...
32019
Historical overview, development and new approaches in the design of angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Part I.
I Drapak, O Kamenetska, LO Perekhoda, IA Sych
Scripta Scientifica Pharmaceutica, 2016
32016
Der Pharma Chemica, 2016
HO Yeromina, IV Drapak, LO Perekhoda, VD Yaremenko, ...
Vol. 8, Is 3, 64-70, 0
3
Synthesis of Some С5 Substituted 4-Phenylimino-Thiazolidin-2-Ones as Possible Anti-Inflammatory Agents
Z Сhulovska, T Chaban, I Drapak, V Matiychuk, I Chaban, I Nektegaev
Biointerface Research in Applied Chemistry 11, 8009-8017, 2021
22021
LC-MS/MS method development and validation for the determination of cardiazol in human plasma
IV Drapak, BS Zimenkovsky, LO Perekhoda, SM Kovalenko, L Logoyda
International Journal of Applied Pharmaceutics, 2019
22019
Development and validation of LC-MS/MS method for estimation of urocarb in human plasma
IV Drapak, BS Zimenkovsky, LO Perekhoda, SM Kovalenko, L Logoyda
International Journal of Applied Pharmaceutics, 2019
22019
Historical overview, development and new approaches in the design of angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Part I.
I Drapak, O Kamenetska, LO Perekhoda, IA Sych
Scripta Scientifica Pharmaceutica, 2016
22016
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20